Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection

Effective treatments for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed. Dexamethasone has been shown to confer survival benefits to certain groups of hospitalized patients, but whether glucocorticoids such as dexamethas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zi-Wei, Yuan, Shuofeng, Chan, Jasper Fuk-Woo, Zhang, Anna Jinxia, Yu, Ching-Yun, Ong, Chon Phin, Yang, Dong, Chan, Chris Chun-Yiu, Tang, Kaiming, Cao, Jianli, Poon, Vincent Kwok-Man, Chan, Chris Chung-Sing, Cai, Jian-Piao, Chu, Hin, Yuen, Kwok-Yung, Jin, Dong-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919885/
https://www.ncbi.nlm.nih.gov/pubmed/33538646
http://dx.doi.org/10.1080/22221751.2021.1885998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919885/
https://www.ncbi.nlm.nih.gov/pubmed/33538646
http://dx.doi.org/10.1080/22221751.2021.1885998

Ejemplares similares